A recent discovery, made at the University of Edinburgh, has uncovered a new possible drug target for the treatment of sleeping sickness, a parasitic infection caused by Trypanosoma brucei, which affects up to 500,000 people across central Africa.The crystal structure of phosphofructokinase, an enzyme involved in glucose metabolism, has revealed structural dissimilarities between the parasite and
Recent comments
33 weeks 5 days ago
37 weeks 3 days ago
1 year 2 weeks ago
1 year 7 weeks ago
1 year 14 weeks ago
1 year 22 weeks ago
1 year 31 weeks ago
1 year 41 weeks ago
1 year 50 weeks ago
1 year 51 weeks ago